Submitted by Anonymous (not verified) on 4 May 2026 - 15:19
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 3, Status: Authorised